Key Highlights
- Exxon Mobil (XOM) advanced more than 3% on March 27, 2026, defying broader market weakness
- Brent crude prices climbed above $110 per barrel after Strait of Hormuz supply challenges
- Approximately 17.8 million barrels daily of oil flow has been interrupted in the critical waterway
- Trump administration pushed back Iran negotiation deadline by 10 days to April 6
- Morgan Stanley elevated XOM price target from $134 to $172 while maintaining Overweight stance
Exxon Mobil (XOM) posted gains exceeding 3% during Friday’s trading session on March 27, defying broader market weakness as surging petroleum prices provided substantial support to energy sector equities.
Major indices closed lower that day, with the S&P 500 declining 0.8%, the Dow Jones Industrial Average dropping 0.9%, and the Nasdaq Composite sliding 1.1%. XOM emerged as a notable outperformer amid the selloff.
The primary catalyst was an extraordinary spike in international crude oil valuations. Brent crude futures traded north of $110 per barrel during midday activity, having previously approached $120 in recent trading sessions following coordinated U.S.-Israeli military operations against Iranian targets on February 28.
The Strait of Hormuz — a critical chokepoint handling approximately 20% of worldwide petroleum transport — has experienced disruptions affecting roughly 17.8 million barrels daily since geopolitical tensions intensified. This supply constraint has propelled prices significantly higher.
By noon Eastern Time on March 27, Brent crude was quoted at $104.28 per barrel. Pricing fluctuated throughout the trading day as new developments continued to emerge.
The Trump administration announced a 10-day extension for Iran to restore access through the Strait of Hormuz, moving the deadline to April 6. President Trump indicated he was “pausing the period of Energy Plant destruction by 10 Days” following requests from Iranian officials.
While this development suggested potential diplomatic progress, supply constraints persisted, maintaining elevated oil prices and continued support for energy equities.
Morgan Stanley Elevates Valuation Target
Morgan Stanley contributed to XOM’s Friday rally by increasing its valuation target on the energy giant to $172 from a previous $134. The investment bank maintained its Overweight recommendation.
Analysts at the firm noted that petroleum, liquefied natural gas, and refining margins had reached their strongest levels since 2022. Their research suggested that even with potential resolution of Iranian tensions, a return to pre-crisis pricing appears improbable.
Morgan Stanley revised its commodity forecasts upward, increasing its 2026 West Texas Intermediate projection by 44%, natural gas liquids by 40%, and refining crack spreads by 35%. Earnings before interest, taxes, depreciation, and amortization projections across the firm’s North American energy sector coverage are climbing approximately 40% for 2026 and 23% for 2027.
Exxon issued no company-specific operational updates on March 27. The stock’s performance was entirely attributed to macroeconomic developments and favorable analyst commentary.
Exxon’s vertically integrated business structure — spanning exploration and production, refining operations, and petrochemical manufacturing — positions the company to capitalize broadly when crude prices escalate. Competitor Chevron and other integrated oil majors similarly posted gains during the session.
Inflation Concerns and Federal Reserve Outlook
With crude pricing exceeding $110 per barrel, market expectations shifted to eliminate any probability of Federal Reserve interest rate reductions in the immediate term. Fed policymakers had previously indicated one potential rate cut might occur during 2026.
Elevated Treasury yields combined with resurgent inflation anxieties pressured technology stocks and broader equity indices. Energy remained among the limited sectors posting positive performance.
Morgan Stanley’s updated commodity projections now support an Exxon price target of $172, representing a 28% increase from the firm’s prior $134 valuation on the stock.
